Certara to Participate in Upcoming Investor Conferences
RADNOR, PA – February 27, 2026 -- Certara, Inc. (Nasdaq: CERT), a global leader in…
CertaraFebruary 27, 2026
Formulate Faster: A Purpose-Built Toolkit for Bioequivalence (Phoenix IVIVC Toolkit)
This webinar introduces the Phoenix IVIVC Toolkit, showing how to perform BE analysis and build…
CertaraFebruary 27, 2026
On Rare Disease Day 2026, Certara experts share how cross-functional innovation, regulatory strategies for rare…
CertaraFebruary 26, 2026
From Documentation to Design: Building a Scalable Metadata Strategy for Clinical Research
Learn how clinical teams are treating metadata as infrastructure to improve reuse, auditability, and standards…
CertaraFebruary 26, 2026
Metatdata as Infrastructure: Designing for Reuse, Insight, and Auditability
Watch this on-demand webinar to learn how leading clinical teams design scalable metadata strategies that…
CertaraFebruary 26, 2026
Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance
FY 2025 Revenue of $418.8M (9% growth) and Adj. EBITDA of $134.5M (10% growth) Fourth…
CertaraFebruary 26, 2026
A Practical Guide to Sales Enablement in Pharma and Life Sciences
Evidence-led strategies for sales enablement in Life Sciences, Pharma, and MedTech. Influence payers & decision…
CertaraFebruary 24, 2026
